Akiko Yasuda

2.3k total citations
40 papers, 1.9k citations indexed

About

Akiko Yasuda is a scholar working on Biochemistry, Nutrition and Dietetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Akiko Yasuda has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biochemistry, 10 papers in Nutrition and Dietetics and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Akiko Yasuda's work include Phytochemicals and Antioxidant Activities (13 papers), Antioxidant Activity and Oxidative Stress (8 papers) and Microbial Metabolites in Food Biotechnology (7 papers). Akiko Yasuda is often cited by papers focused on Phytochemicals and Antioxidant Activities (13 papers), Antioxidant Activity and Oxidative Stress (8 papers) and Microbial Metabolites in Food Biotechnology (7 papers). Akiko Yasuda collaborates with scholars based in Japan and United States. Akiko Yasuda's co-authors include Naomi Osakabe, Midori Natsume, Seigo Baba, Kazuo Kondo, Chiaki Sanbongi, Toshikazu Yoshikawa, Toshio Takizawa, Rie Yanagisawa, Ken‐ichiro Inoue and Hirohisa Takano and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Agricultural and Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Akiko Yasuda

36 papers receiving 1.8k citations

Peers

Akiko Yasuda
Roberta R. Holt United States
MB Katan Netherlands
M. Richelle Switzerland
Javier I. Ottaviani United States
Derek D. Schramm United States
Akiko Yasuda
Citations per year, relative to Akiko Yasuda Akiko Yasuda (= 1×) peers Beatriz Sarriá

Countries citing papers authored by Akiko Yasuda

Since Specialization
Citations

This map shows the geographic impact of Akiko Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Yasuda more than expected).

Fields of papers citing papers by Akiko Yasuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Yasuda. The network helps show where Akiko Yasuda may publish in the future.

Co-authorship network of co-authors of Akiko Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Yasuda. A scholar is included among the top collaborators of Akiko Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Yasuda. Akiko Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasuda, Akiko, et al.. (2025). The 'Silk Road' that Leads to Infliximab: A Severe Case of Behçet's Disease. The American Journal of Medicine. 138(6). 953–955.
2.
Ide, Kaori, Masashi Takahashi, Masanori Kobayashi, et al.. (2024). Development of a sensitive disease-screening model using comprehensive circulating microRNA profiles in dogs: A pilot study. Veterinary and Animal Science. 27. 100414–100414. 1 indexed citations
3.
Kubo, Yoshiaki, et al.. (2023). Expression of type VI collagen α3 chain in canine mammary carcinomas. Research in Veterinary Science. 159. 171–182. 1 indexed citations
4.
Yasuda, Akiko, Akiko Mizote, Manabu Miyata, et al.. (2022). Development of a method for preparing cyclic nigerosylnigerose syrup and investigation of its value as a dietary fiber. Bioscience Biotechnology and Biochemistry. 86(6). 780–791. 4 indexed citations
5.
Kobayashi, Masato, Keita Ito, Akiko Yasuda, et al.. (2013). Imatinib-associated tumour response in a dog with a non-resectable gastrointestinal stromal tumour harbouring a c-kit exon 11 deletion mutation. The Veterinary Journal. 198(1). 271–274. 25 indexed citations
6.
Yasuda, Akiko, Ken‐ichiro Inoue, Chiaki Sanbongi, et al.. (2012). Dietary supplementation with fructooligosaccharides attenuates allergic peritonitis in mice. Biochemical and Biophysical Research Communications. 422(4). 546–550. 23 indexed citations
7.
Nakamura, Yuko, et al.. (2011). Fructooligosaccharides suppress high‐fat diet‐induced fat accumulation in C57BL/6J mice. BioFactors. 43(2). 145–151. 32 indexed citations
8.
Yasuda, Akiko, et al.. (2011). Cacao Polyphenols Influence the Regulation of Apolipoprotein in HepG2 and Caco2 Cells. Journal of Agricultural and Food Chemistry. 59(4). 1470–1476. 38 indexed citations
9.
Yasuda, Akiko, Chiaki Sanbongi, Rie Yanagisawa, et al.. (2010). Dietary Supplementation with Fructooligosaccharides Attenuates Airway Inflammation Related to House Dust Mite Allergen in Mice. International Journal of Immunopathology and Pharmacology. 23(3). 727–735. 19 indexed citations
10.
Yasuda, Akiko, H. Takano, Naomi Osakabe, et al.. (2008). Cacao Liquor Proanthocyanidins Inhibit Lung Injury Induced by Diesel Exhaust Particles. International Journal of Immunopathology and Pharmacology. 21(2). 279–288. 7 indexed citations
11.
Yasuda, Akiko, Midori Natsume, Seigo Baba, et al.. (2008). Cacao procyanidins reduce plasma cholesterol and increase fecal steroid excretion in rats fed a high‐cholesterol diet. BioFactors. 33(3). 211–223. 43 indexed citations
12.
Baba, Seigo, Naomi Osakabe, Yoji Kato, et al.. (2007). Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. American Journal of Clinical Nutrition. 85(3). 709–717. 183 indexed citations
13.
Baba, Seigo, Midori Natsume, Akiko Yasuda, et al.. (2007). Plasma LDL and HDL Cholesterol and Oxidized LDL Concentrations Are Altered in Normo- and Hypercholesterolemic Humans after Intake of Different Levels of Cocoa Powder. Journal of Nutrition. 137(6). 1436–1441. 130 indexed citations
14.
Natsume, Midori, Naomi Osakabe, Akiko Yasuda, et al.. (2004). In VitroAntioxidative Activity of (−)-Epicatechin Glucuronide Metabolites Present in Human and Rat Plasma. Free Radical Research. 38(12). 1341–1348. 49 indexed citations
15.
Osakabe, Naomi, Hirohisa Takano, Chiaki Sanbongi, et al.. (2004). Anti‐inflammatory and anti‐allergic effect of rosmarinic acid (RA); inhibition of seasonal allergic rhinoconjunctivitis (SAR) and its mechanism. BioFactors. 21(1-4). 127–131. 140 indexed citations
16.
Osakabe, Naomi, Akiko Yasuda, Midori Natsume, et al.. (2002). Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in d-galactosamine (d-GalN)-sensitized mice. Free Radical Biology and Medicine. 33(6). 798–806. 173 indexed citations
17.
Osakabe, Naomi, Seigo Baba, Akiko Yasuda, et al.. (2001). Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxidation as demonstrated in healthy human volunteers. Free Radical Research. 34(1). 93–99. 108 indexed citations
18.
Akino, Kozo, Akira Ohtsuru, Akiko Yasuda, et al.. (2000). Parathyroid Hormone-Related Peptide Is a Potent Tumor Angiogenic Factor. Endocrinology. 141(11). 4313–4316. 44 indexed citations
19.
Baba, Seigo, Naomi Osakabe, Akiko Yasuda, et al.. (2000). Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radical Research. 33(5). 635–641. 193 indexed citations
20.
Fujii, Yuko, et al.. (1958). The tuberous sclerosis complex; a study of a new case.. PubMed. 65(2). 166–73. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026